BIOLIFE SOLUTIONS INC
BLFSNasdaq
$29.15
↓ -3.7%Jul 17 close · end-of-day
Price
1Y↑ +38.5%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$1.4B
Enterprise Value
$1.4B
P/E
—
P/S
14.1
P/B
3.9
EV/EBITDA
—
PEG
—
FCF Yield
—
Dividend Yield
—
Revenue (TTM)
$101.7M
Net Income (TTM)
-$3.0M
Free Cash Flow (TTM)
—
Gross Margin
—
Operating Margin
-15.8%
Net Margin
-2.9%
ROE
-0.8%
ROIC
-4.3%
Debt / Equity
0.0
Net Cash
$78.5M
Return 1Y
+36.1%
Company profile
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for cell and gene therapy industry. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor.
- CEO
- Michael P. Rice
- Sector
- Manufacturing
- Industry
- Medical Equipment
- Employees
- 440
- Headquarters
- Washington
- Website
- biolifesolutions.com
Management & directors
- Berard ToddChief Marketing Officer
- Mathew Aby J.EVP & Chief Scientific Officer
- Wichterman TroyChief Financial Officer
- De Greef RoderickPresident and CEO
- Werner SeanChief Technology Officer
- Foster Karen A.Chief Quality and Operations
- Aebersold SarahChief Human Resources Officer
Roles derived from SEC Form 4 filings.
Earnings
BLFS Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$27.5M↑ +24.7%
Diluted EPS$0.02—
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $48.1M | $119.2M | $76.2M | $68.0M | $74.6M | $96.2M |
| Gross profit | — | — | — | $41.3M | $50.1M | $62.1M |
| Operating income | -$6.2M | -$35.2M | -$5.9M | -$17.2M | -$4.5M | -$16.6M |
| Net income | $2.0M | -$8.9M | -$139.8M | -$68.0M | -$20.2M | -$4.6M |
| Diluted EPS | -$0.06 | -$0.23 | -$3.25 | -$1.55 | -$0.44 | -$0.10 |
| Operating cash flow | $6.6M | -$4.6M | -$8.5M | -$12.5M | $8.4M | $20.1M |
| Free cash flow | $4.7M | -$13.0M | -$18.9M | -$18.9M | $5.2M | $10.6M |
| Gross margin | — | — | — | 60.7% | 67.1% | 64.6% |
| Operating margin | -13.0% | -29.5% | -7.8% | -25.3% | -6.0% | -17.3% |
| Net margin | 4.1% | -7.5% | -183.4% | -100.0% | -27.0% | -4.8% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $19.7M | $21.4M | $15.1M | $22.1M | $25.4M | $28.1M | $20.7M | $27.5M |
| Gross profit | — | — | — | $14.8M | — | — | — | $17.5M |
| Operating income | -$1.3M | -$418,000.00 | $542,000.00 | -$499,000.00 | -$16.6M | -$89,000.00 | $629,000.00 | $27,000.00 |
| Net income | -$20.7M | -$1.7M | $12.5M | -$448,000.00 | -$15.8M | $621,000.00 | $11.1M | $1.2M |
| Diluted EPS | -$0.45 | -$0.04 | $0.27 | $0.00 | -$0.33 | $0.01 | $0.22 | $0.02 |
| Operating cash flow | $6.5M | $4.8M | $1.6M | $1.7M | $7.4M | $6.1M | $4.9M | -$491,000.00 |
| Free cash flow | — | — | — | $1.6M | — | — | — | -$658,000.00 |
| Gross margin | — | — | — | 67.1% | — | — | — | 63.6% |
| Operating margin | -6.6% | -2.0% | 3.6% | -2.3% | -65.5% | -0.3% | 3.0% | 0.1% |
| Net margin | -105.1% | -8.0% | 82.5% | -2.0% | -62.3% | 2.2% | 53.6% | 4.3% |
Company news
Jun 18, 2026
Jun 4, 2026
May 29, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-07-07 | Wichterman Troy· Chief Financial Officer | Tax withholding | 844 | $27.79 | $23,454.76 | filing |
| 2026-07-07 | Mathew Aby J.· EVP & Chief Scientific Officer | Tax withholding | 516 | $27.79 | $14,339.64 | filing |
| 2026-07-07 | Berard Todd· Chief Marketing Officer | Tax withholding | 293 | $27.79 | $8,142.47 | filing |
| 2026-06-18 | DE GREEF RODERICK· President and CEO | Tax withholding | 2,775 | $26.04 | $72,261.00 | filing |
| 2026-06-18 | Wichterman Troy· Chief Financial Officer | Tax withholding | 937 | $26.04 | $24,399.48 | filing |
| 2026-06-18 | Mathew Aby J.· EVP & Chief Scientific Officer | Tax withholding | 564 | $26.04 | $14,686.56 | filing |
| 2026-06-18 | Berard Todd· Chief Marketing Officer | Tax withholding | 470 | $26.04 | $12,238.80 | filing |
| 2026-06-18 | Werner Sean· Chief Technology Officer | Tax withholding | 420 | $26.04 | $10,936.80 | filing |
| 2026-06-08 | Wichterman Troy· Chief Financial Officer | Tax withholding | 1,026 | $26.10 | $26,778.60 | filing |
| 2026-06-08 | Mathew Aby J.· EVP & Chief Scientific Officer | Tax withholding | 627 | $26.10 | $16,364.70 | filing |
| 2026-06-08 | Berard Todd· Chief Marketing Officer | Tax withholding | 356 | $26.10 | $9,291.60 | filing |
| 2026-05-21 | Casdin Partners Master Fund, L.P. | Sale | 650,000 | $23.70 | $15.4M | filing |
| 2026-05-20 | Casdin Partners Master Fund, L.P. | Sale | 250,000 | $23.70 | $5.9M | filing |
| 2026-05-19 | Casdin Partners Master Fund, L.P. | Sale | 300,000 | $22.65 | $6.8M | filing |
| 2026-04-08 | Wichterman Troy· Chief Financial Officer | Tax withholding | 844 | $19.27 | $16,263.88 | filing |
| 2026-04-08 | Mathew Aby J.· EVP & Chief Scientific Officer | Tax withholding | 515 | $19.27 | $9,924.05 | filing |
| 2026-04-08 | Berard Todd· Chief Marketing Officer | Tax withholding | 293 | $19.27 | $5,646.11 | filing |
| 2026-03-23 | Foster Karen A.· Chief Quality and Operations | Sale | 2,577 | $19.17 | $49,401.09 | filing |
| 2026-03-19 | DE GREEF RODERICK· President and CEO | Tax withholding | 11,101 | $19.12 | $212,251.12 | filing |
| 2026-03-19 | Wichterman Troy· Chief Financial Officer | Tax withholding | 3,749 | $19.12 | $71,680.88 | filing |
| 2026-03-19 | Mathew Aby J.· EVP & Chief Scientific Officer | Tax withholding | 2,255 | $19.12 | $43,115.60 | filing |
| 2026-03-19 | Foster Karen A.· Chief Quality and Operations | Tax withholding | 1,907 | $19.12 | $36,461.84 | filing |
| 2026-03-19 | Berard Todd· Chief Marketing Officer | Tax withholding | 1,879 | $19.12 | $35,926.48 | filing |
| 2026-03-19 | Werner Sean· Chief Technology Officer | Tax withholding | 1,681 | $19.12 | $32,140.72 | filing |
| 2026-03-19 | Aebersold Sarah· Chief Human Resources Officer | Tax withholding | 931 | $19.12 | $17,800.72 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.